Stoke Therapeutics STOK
NASDAQ STOK
$25.68 -0.93 (-3.49%)
At close: Oct 21, 2026 · 4:00 PM EDT

Stoke Therapeutics (STOK) EV to EBIT (2025)

Updated

Stoke Therapeutics' (STOK) EV to EBIT came in at 38.50 for Q3 2025, up 315.3% from the prior quarter.

Analysis

Stoke Therapeutics (STOK) EV to EBIT (2025) Analysis & Trends

For the trailing twelve months through Sep 30, 2025, EV to EBIT at Stoke Therapeutics was 8.28.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Stoke Therapeutics 1.70 Bn 529.30 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 38.50
Jun 30, 2025 9.27
Mar 31, 2025 0.15
API Access

Stoke Therapeutics EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=STOK&period=max&api_key=YOUR_API_KEY